Shin-Etsu Chemical Co., Ltd. (TYO:4063)
5,845.00
+45.00 (0.78%)
Aug 3, 2026, 3:30 PM JST
Shin-Etsu Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,607,844 | 2,573,969 | 2,561,249 | 2,414,937 | 2,808,824 | 2,074,428 | |
Revenue Growth | 0.62% | 0.50% | 6.06% | -14.02% | 35.40% | 38.58% |
Cost of Revenue | 1,723,049 | 1,693,175 | 1,577,127 | 1,503,728 | 1,594,717 | 1,206,425 |
Gross Profit | 884,795 | 880,794 | 984,122 | 911,209 | 1,214,107 | 868,003 |
Selling, General & Admin | 242,595 | 237,876 | 235,072 | 204,441 | 213,090 | 188,677 |
Operating Expenses | 242,595 | 245,588 | 242,016 | 210,171 | 215,905 | 195,320 |
Operating Income | 642,200 | 635,206 | 742,106 | 701,038 | 998,202 | 672,683 |
Interest Expense | -2,706 | -2,706 | - | -1,501 | -1,490 | - |
Interest & Investment Income | 60,361 | 62,927 | 86,732 | 67,959 | 16,575 | - |
Earnings From Equity Investments | - | - | - | - | 9,522 | 7,140 |
Currency Exchange Gain (Loss) | - | - | -10,687 | 13,648 | -3,195 | 14,265 |
Other Non Operating Income (Expenses) | 22,784 | 16,703 | 6,620 | 8,310 | 5,506 | 3,159 |
EBT Excluding Unusual Items | 722,639 | 712,130 | 824,771 | 789,454 | 1,025,120 | 697,247 |
Gain (Loss) on Sale of Investments | 9,919 | 10,572 | 16,424 | 19,178 | - | - |
Gain (Loss) on Sale of Assets | - | -3,850 | -4,228 | -2,226 | -4,910 | -1,111 |
Asset Writedown | -3,850 | - | -2,896 | - | - | - |
Other Unusual Items | - | -10,365 | -7,842 | -10,733 | - | - |
Pretax Income | 718,343 | 708,487 | 826,229 | 795,673 | 1,020,210 | 696,136 |
Income Tax Expense | 209,611 | 202,198 | 246,128 | 230,513 | 256,590 | 171,105 |
Earnings From Continuing Operations | 508,732 | 506,289 | 580,101 | 565,160 | 763,620 | 525,031 |
Minority Interest in Earnings | -29,872 | -31,830 | -46,080 | -45,020 | -55,382 | -24,914 |
Net Income | 478,860 | 474,459 | 534,021 | 520,140 | 708,238 | 500,117 |
Net Income to Common | 478,860 | 474,459 | 534,021 | 520,140 | 708,238 | 500,117 |
Net Income Growth | -7.27% | -11.15% | 2.67% | -26.56% | 41.61% | 70.26% |
Shares Outstanding (Basic) | 1,867 | 1,878 | 1,981 | 2,005 | 2,036 | 2,077 |
Shares Outstanding (Diluted) | 1,869 | 1,879 | 1,983 | 2,007 | 2,037 | 2,079 |
Shares Change | -4.63% | -5.25% | -1.20% | -1.49% | -2.00% | -0.02% |
EPS (Basic) | 256.50 | 252.68 | 269.52 | 259.41 | 347.84 | 240.76 |
EPS (Diluted) | 256.20 | 252.49 | 269.27 | 259.13 | 347.61 | 240.55 |
EPS Growth | -2.78% | -6.23% | 3.91% | -25.45% | 44.51% | 70.30% |
Free Cash Flow | 379,531 | 359,031 | 442,461 | 380,766 | 492,496 | 357,753 |
Free Cash Flow Per Share | 203.08 | 191.09 | 223.13 | 189.72 | 241.73 | 172.08 |
Dividend Per Share | 106.000 | 106.000 | 106.000 | 100.000 | 100.000 | 80.000 |
Dividend Growth | 0% | 0% | 6.00% | 0% | 25.00% | 60.00% |
Gross Margin | 33.93% | 34.22% | 38.42% | 37.73% | 43.23% | 41.84% |
Operating Margin | 24.63% | 24.68% | 28.97% | 29.03% | 35.54% | 32.43% |
Profit Margin | 18.36% | 18.43% | 20.85% | 21.54% | 25.21% | 24.11% |
Free Cash Flow Margin | 14.55% | 13.95% | 17.27% | 15.77% | 17.53% | 17.25% |
EBITDA | 885,373 | 878,179 | 980,463 | 928,657 | 1,211,834 | 841,471 |
EBITDA Margin | 33.95% | 34.12% | 38.28% | 38.45% | 43.14% | 40.56% |
D&A For EBITDA | 243,173 | 242,973 | 238,357 | 227,619 | 213,632 | 168,788 |
EBIT | 642,200 | 635,206 | 742,106 | 701,038 | 998,202 | 672,683 |
EBIT Margin | 24.63% | 24.68% | 28.97% | 29.03% | 35.54% | 32.43% |
Effective Tax Rate | 29.18% | 28.54% | 29.79% | 28.97% | 25.15% | 24.58% |